infigratinib
Sign in to saveInfigratinib is an kinase inhibitor in development for the treatment of achondroplasia and hypochondroplasia.
Chemical data
- Formula
- C26H31Cl2N7O3
- Molecular weight
- 560.5 g/mol
- IUPAC name
- 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea
via PubChem
Article
6 sectionsContents
- Medical uses
- History
- Society and culture
- Legal status
- References
- External links
Infigratinib is an kinase inhibitor in development for the treatment of achondroplasia and hypochondroplasia.
Infigratinib targets the fibroblast growth factor receptors FGFR1, FGFR2, and FGFR3.